Memorias de investigación
Communications at congresses:
Artificial-Intelligence-Augmented Telemedicine Applied to the Management of Diet-Treated Gestational Diabetes
Year:2015
Research Areas
  • Electronic technology and of the communications
Information
Abstract
Gestational diabetes (GD) confers an increased risk of complications as well as future type 2 diabetes. We assess the safety and efficacy of an artificial intelligence (AI)-augmented telemedicine system (ruled-based reasoning) that includes a blood glucose (BG) classifier (C4.5 Quinlan decision tree) in comparison with the standard care in the management of GD while insulin is not required.
International
Si
Congress
15th Annual Diabetes Technology Meeting (DTM)
970
Place
Bethesda, Maryland. USA
Reviewers
Si
ISBN/ISSN
1932-2968
10.1177/1932296816639698
Start Date
20/10/2015
End Date
22/10/2015
From page
86
To page
86
Journal of Diabetes Science and Technology
Participants
Research Group, Departaments and Institutes related
  • Creador: Grupo de Investigación: Grupo de Bioingeniería y Telemedicina
  • Centro o Instituto I+D+i: Centro de tecnología Biomédica CTB
  • Departamento: Tecnología Fotónica y Bioingeniería